Literature DB >> 12016138

Genetics and new approaches to cancer therapy.

Webster K Cavenee1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12016138     DOI： 10.1093/carcin/23.5.683

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN： 0143-3334            Impact factor:   4.944


× No keyword cloud information.
  8 in total

1.  Screening phage display libraries for organ-specific vascular immunotargeting in vivo.

Authors:  Philippe Valadon; Jeff D Garnett; Jacqueline E Testa; Marc Bauerle; Phil Oh; Jan E Schnitzer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-29       Impact factor: 11.205

2.  An in vitro study on the suppressive effect of glioma cell growth induced by plasmid-based small interference RNA (siRNA) targeting human epidermal growth factor receptor.

Authors:  Chun-Sheng Kang; Pei-Yu Pu; Yan-He Li; Zhi-Yong Zhang; Ming-Zhe Qiu; Qiang Huang; Guang-Xiu Wang
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

3.  Analysis of phosphotyrosine signaling in glioblastoma identifies STAT5 as a novel downstream target of ΔEGFR.

Authors:  Vaibhav Chumbalkar; Khatri Latha; YeoHyeon Hwang; Rebecca Maywald; Lauren Hawley; Raymond Sawaya; Lixia Diao; Keith Baggerly; Webster K Cavenee; Frank B Furnari; Oliver Bogler
Journal:  J Proteome Res       Date:  2011-02-14       Impact factor: 4.466

4.  Genetic analysis of intracranial tumors in a murine model of glioma demonstrate a shift in gene expression in response to host immunity.

Authors:  Chris A Learn; Peter M Grossi; Robert J Schmittling; Weihua Xie; Duane A Mitchell; Isaac Karikari; ZhengZheng Wei; Holly Dressman; John H Sampson
Journal:  J Neuroimmunol       Date:  2006-11-29       Impact factor: 3.478

5.  Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cells.

Authors:  Jeannine Garnett; Vaibhav Chumbalkar; Brian Vaillant; Anupama E Gururaj; Kristen S Hill; Khatri Latha; Jun Yao; Waldemar Priebe; Howard Colman; Lisa A Elferink; Oliver Bogler
Journal:  Neoplasia       Date:  2013-01       Impact factor: 5.715

6.  Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma.

Authors:  Paul H Huang; Akitake Mukasa; Rudy Bonavia; Ryan A Flynn; Zachary E Brewer; Webster K Cavenee; Frank B Furnari; Forest M White
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-23       Impact factor: 11.205

7.  Epidermal growth factor receptor in glioblastoma.

Authors:  Hongsheng Xu; Hailiang Zong; Chong Ma; Xing Ming; Ming Shang; Kai Li; Xiaoguang He; Hai Du; Lei Cao
Journal:  Oncol Lett       Date:  2017-05-22       Impact factor: 2.967

8.  Cancer association study of aminoacyl-tRNA synthetase signaling network in glioblastoma.

Authors:  Yong-Wan Kim; Changhyuk Kwon; Juinn-Lin Liu; Se Hoon Kim; Sunghoon Kim
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.